THRiVE Consortium For Health Research Capacity Building
PARTNER INSTITUTIONS Regional Institutional Collaborations
TRAINING AND MENTORSHIP Post doctoral & PhD fellowship training
Network Resources THRiVE Shared Resources

THRiVE in the News

Check out the latest newsletter issue and get updated on recent THRiVE research activities

Current THRiVE Publications - 2019

01 Nasuuna E, Kigozi J, Muwanguzi PA, Babirye J, Kiwala L, Muganzi A, Sewankambo N, Nakanjako D. Challenges faced by caregivers of virally non-suppressed children on the intensive adherence counselling program in Uganda: a qualitative study. BMC Health Serv Res. 2019 Mar 7;19(1):150. doi: 10.1186/s12913-019-3963-y.
02 Makanda M, Kemunto G, Wamuyu L, Bargul JL, Muema J, Mutunga J. Diversity and Molecular Characterization of Mosquitoes (Diptera: Culicidae) in selected ecological regions in Kenya. F1000Research 2019, 8:262
03 Kwizera R, Akampurira A, Kandole TK, Nabaggala MS, Williams DA, Kambugu A, Meya DB, Rhein J, Boulware DR; ASTRO Team. Evaluation of trypan blue stain in the TC20 automated cell counter as a point-of-care for the enumeration of viable cryptococcal cells in cerebrospinal fluid. Med Mycol. 2018 Jul 1;56(5):559-564. doi: 10.1093/mmy/myx076.
04 Ssebambulidde K, Bangdiwala AS, Kwizera R, Kandole TK, Tugume L, Kiggundu R, Mpoza E, Nuwagira E, Williams DA, Lofgren SM, Abassi M, Musubire AK, Cresswell FV, Rhein J, Muzoora C, Hullsiek KH, Boulware DR, Meya DB; ASTRO-CM team. Symptomatic cryptococcal antigenemia presenting as early cryptococcal meningitis with negative CSF analysis. Clin Infect Dis. 2018 Sep 25. doi: 10.1093/cid/ciy817. PMID: 30256903
05 Kavuma Mwanje A, Ejoku J, Ssemogerere L et al. Association between CD4 T cell counts and the immune status among adult critically ill HIV-negative patients in intensive care units in Uganda. AAS Open Res 2019, 2:2
06 Kakooza-Mwesige A, Tshala-Katumbay D, Juliano SL. Viral infections of the central nervous system in Africa. Brain Res Bull. 2019 Jan 15. pii: S0361-9230(18)30341-1. doi: 10.1016/j.brainresbull.2018.12.019 PMID: 30658129
07 Okubo T, Yossapol M, Maruyama F, Wampande EM, Kakooza S, Ohya K,  Tsuchida S,  Asai T,  Kabasa JD, Ushida K. Phenotypic and genotypic analyses of antimicrobial resistant bacteria in livestock in Uganda. Transbound Emerg Dis, 2018.
08 Meya DB, Kiragga AN, E Nalintya E, Morawski BM, Rajasingham R, Park BJ, Mubiru A, Kaplan JE, Manabe YC, and Boulware DR, on behalf of the ORCAS study team. Reflexive laboratory-based cryptococcal antigen screening and preemptive fluconazole therapy for cryptococcal antigenemia in HIV-infected individuals with CD4. J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):182-189. doi: 10.1097/QAI.0000000000001894.
09 Mayito J, Andia I, Belay M, Jolliffe DA, Kateete DP, Reece ST, and Martineau AR. Anatomic and Cellular Niches for Mycobacterium tuberculosis in Latent Tuberculosis Infection. The Journal of Infectious Diseases, jiy579,
10 TR Okello, D Ocen, J Okello, I Pecorella, D Amone. Case Report: Biloma gastrostomy after failed sonogram-guided percutaneous aspiration, pigtail catheter insertion and surgical drainage AAS Open Research 2018, 1:19
11 D Amone, C Okot, P Mugabi, TR Okello, DM Ogwang. Case Report: Swallowed toothbrush in the stomach of a 56 year female at St Mary’s Hospital Lacor, Uganda. AAS Open Res 2018, 1:5
12 Buhikire K, Voss J, Kigozi J, Nyakato P, Ankunda N, Kalebbo B, Musiitwa M, Muganzi A, Sewankambo NK, Nakanjako D. Reaching the First 90 in Uganda: Predictors of Success in Contacting and Testing the Named Sexual Partners of HIV+ Index Clients in Kiboga District. AIDS Behav 2018 May 12. doi: 10.1007/s10461-018-2137-y.
13 Mboowa G, Mwesigwa S, Katagirya E et al. The Collaborative African Genomics Network (CAfGEN): Applying Genomic technologies to probe host factors important to the progression of HIV and HIV-tuberculosis infection in sub-Saharan Africa [version 1; referees: awaiting peer review]. AAS Open Res 2018, 1:3 (doi: 10.12688/aasopenres.12832.1)
14 Mboowa G, Sserwadda A, Amujal M, Namatovu N. Human Genomic Loci Important in Common Infectious Diseases: Role of High-Throughput Sequencing and Genome-Wide Association Studies. Canadian Journal of Infectious Diseases and Medical Microbiology Volume 2018 (2018), Article ID 1875217
15 Mugisa GA, Kiondo P and Namagembe I. Single dose ceftriaxone and metronidazole versus multiple doses for antibiotic prophylaxis at elective caesarean section in Mulago hospital: A randomized clinical trial AAS Open Research 2018, 1:11 (doi: 10.12688/aasopenres.12849.1)
16 Olusanya BO, Davis AC, Wertlieb D, Nem-Yun Boo, Nair MKC, Halpern R, Kuper H, Breinbauer C, Petrus J de Vries, Gladstone M, Halfon N, Kancherla V, Mulaudzi MC, Kakooza-Mwesige A et al. Developmental disabilities among children younger than 5 years in 195 countries and territories, 1990– 2016: a systematic analysis for the Global Burden of Disease Study 2016. Developmental disabilities among children younger than 5 years in 195 countries and territories, 1990– 2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Glob Health 2018 Published Online August 29, 2018
17 Kakooza-Mwesige A, Ndyomugyenyi D, Pariyo G, Peterson SS, Waiswa PM, Galiwango E, Chengo E, Odhiambo R, Ssewanyana D, Bottomley C, Ngugi AK, Newton CRJC; SEEDS Writing Group. Adverse perinatal events, treatment gap, and positive family history linked to the high burden of active convulsive epilepsy in Uganda: A population-based study. Epilepsia Open. 2017 Mar 13;2(2):188-198. doi: 10.1002/epi4.12048. eCollection 2017 Jun. PMID: 29588948
18 Nsangi A, Semakula D, Oxman AD, Austvoll-Dahlgren A, Oxman M, Rosenbaum S, Morelli A, Glenton C, Lewin S, Kaseje M, Chalmers I, Fretheim A, Ding Y, Sewankambo NK. Effects of the Informed Health Choices primary school intervention on the ability of children in Uganda to assess the reliability of claims about treatment effects: a cluster-randomised controlled trial. The Lancet , Volume 390 , Issue 10092 , p374 – 388, 22017. DOI:
19 Semakula D, Nsangi A, Oxman AD, Oxman M, Austvoll-Dahlgren A, Rosenbaum S, Morelli A, Glenton C, Lewin S, Kaseje M, Chalmers I, Fretheim PA, Kristoffersen DT, NK Sewankambo. Effects of the Informed Health Choices podcast on the ability of parents of primary school children in Uganda to assess claims about treatment effects: a randomised controlled trial. The Lancet , Volume 390 , Issue 10092, p389–398, 22 July 2017 DOI:
20 Nakanjako D, Akena D, Kaye V, Tumwine J, Okello E, Nakimuli A, Kambugu A, McCullough H, Mayanja-Kizza, Kamya MR, Sewankambo NK. A need to accelerate health research productivity in an African University: the case of Makerere University College of Health Sciences. Health Res Policy Syst. 2017 Apr 21;15(1):33. doi: 10.1186/s12961-017-0196-6
21 Sewankambo NK. HIV incidence and scale-up of prevention in western Kenya The Lancet HIV HIV 2018
22 Sewankambo NK, Mafigiri DK. Educating religious leaders to create demand for medical male circumcision. The Lancet
23 Longenecker CT, Morris SR, Aliku TO, Beaton A, Costa MA, Kamya MR, Kityo C, Lwabi P, Mirembe G, Nampijja D, Rwebembera J, Sable C, Salata RA, Scheel A, Simon DI, I Ssinabulya I, Okello E. Rheumatic Heart Disease Treatment Cascade in Uganda. Circ Cardiovasc Qual Outcomes. 2017;10:e004037. DOI: 10.1161/CIRCOUTCOMES.117.004037
24 Kakooza-Mwesige A, Ndyomugyenyi D, Pariyo F, Peterson SS, Waiswa PM, Galiwango E, Chengo E, Odhiambo R, Ssewanyana D, Bottomley C, Ngugi AK, Newton CRJC, and a on behalf of the SEEDS Writing Group Epilepsia. Adverse perinatal events, treatment gap, and positive family history linked to the high burden of active convulsive epilepsy in Uganda: A population-based study. Epilepsia Open, 2(2):188–198, 2017 doi: 10.1002/epi4.12048

PhD Funded Work

1 Galukande M, Wabinga H, Mirembe F, Karamagi C. Patient Delay in accessing Breast Cancer Care in a sub Saharan African country: Uganda.  British Journal of Medicine and Medical Research 2014;  4(13): 2599-2610
2 Galukande M,  Wabinga H, Mirembe F, Karamagi C, Asea A.  Molecular breast cancer subtypes prevalence in an indigenous Sub Saharan African population. The Pan African Medical Journal 2014; 17:249
3 Mazigo HD, Dunne DW, Kinung’hi SM and Nuwaha F. Praziquantel efficacy against Schistosoma mansoni among HIV-1 infected and uninfected adults living in fishing villages along Lake Victoria, Northwest Tanzania. Infectious Diseases of Poverty 2014, 3:47  doi:10.1186/2049-9957-3-47
4 Nankabirwa JI, Wandera B, Amuge P, Kiwanuka N, Dorsey G, et al. (2014) Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in Ugandan schoolchildren: a randomized, placebo-controlled trial. Clin Infect Dis 58: 1404-1412.
5 D.B. Meya; S. Okurut; G. Zziwa; M.A. Rolfes; K. Melander; S. Cose; M. Joloba; P. Naluyima; B.E. Palmer; A. Kambugu; H. Mayanja-Kizza; P.R. Bohjanen; M.A. Eller; S.M. Wahl; D.R. Boulware; Y.C. Manabe; E.N. Janoff. Cellular Immune Activation in Cerebrospinal Fluid from Ugandans with Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome. Journal of Infectious Diseases 2014;
doi: 10.1093/infdis/jiu664
6 Mpogoro FJ, Matovelo D, Dosani A, Ngallaba S, Mugono M and Mazigo HD. Uptake of intermittent preventive treatment with sulphadoxine-pyrimethamine for malaria during pregnancy and pregnancy outcomes: a cross-sectional study in Geita district, North-Western Tanzania Malaria Journal 2014, 13:455  doi:10.1186/1475-2875-13-455
7 Kiguba R, Karamagi C, Waako P, Ndagije HB, Bird SM.  Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants BMJ Open 2014;4:e005869doi:10.1136/bmjopen-2014-005869
8 Jimmy Ronald Andi, Robert Wamala, Bruon Ocaya, Allen Kabagenyi.  Modern contraceptive use among women in Uganda: An analysis of trend and patterns    (1995-2011) African Population Studies Journal: 2014; 28(2) http://aps.journals.ac.za/pub/article/view/553
9 Book Chapter: HD. Mazigo, Rebecca Waihenya and Domenica Morona (2014). Schistosomiasis in school children in sub-Saharan African: Epidemiology, signs and symptoms, diagnosis, treatment options and the challenges in Schistosomiaisis Epidemiology, Diagnosis and Treatment. Edited by Adriana Erica Miele. Nova Science Publishers
10 Liya M. Assefa, Thomas Crellen, Stella Kepha, Jimmy H. Kihara, Sammy M. Njenga,  Rachel L. Pullan, Simon J. Brooker. Diagnostic Accuracy and Cost-Effectiveness of Alternative Methods for Detection of Soil-Transmitted Helminths in a Post-Treatment Setting in Western Kenya. PLOS Neglected Tropical Diseases. May 2014 8(5) e2843
11 David R. Boulware, David B. Meya, Conrad Muzoora, M. Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis. N Engl J Med 2014;370:2487-98.DOI: 10.1056/NEJMoa1312884
12 Mwaka A.D., Okello E.S. & Orach C.G. Barriers to biomedical care and use of traditional medicines for treatment of cervical cancer: an exploratory qualitative study in northern Uganda.  Eur J Cancer Care (Engl). 2014 Jun 13. doi: 10.1111/ecc.12211.
13 Doris Mutabazi-Mwesigire, Janet Seeley, Faith Martin and Achilles Katamba. Perceptions of quality of life among Ugandan patients living with HIV: a qualitative study. BMC Public Health 2014, 14:343  doi:10.1186/1471-2458-14-343.
14 Allen Kabagenyi, Patricia Ndugga, Stephen Ojiambo Wandera and Betty Kwagala. Modern contraceptive use among sexually active men in Uganda: does discussion with a health worker matter? BMC Public Health 2014, 14:286 2-8 http://www.biomedcentral.com/1471-2458/14/286
15 Kabagenyi  Allen, Jennings  Larissa, Reid  Alice, Nalwadda  Gorette, Ntozi  James, Atuyambe  Lynn. Barriers to male involvement in contraceptive uptake and reproductive health services: a qualitative study of men and women’s perceptions in two rural districts in Uganda. Journal: Reproductive Health Reproductive Health.2014, 11:21 OI: 10.1186/1742-4755-11-21. . J. Antimicrob. hemother. (2014)doi: 10.1093/jac/dku087http://www.reproductive-health-journal.com/content/11/1/21
16 Amos D Mwaka, Henry R Wabinga and Harriet Mayanja-Kizza. Mind the gaps: a qualitative study of perceptions of healthcare professionals on challenges and proposed remedies for cervical cancer help-seeking in post conflict northern Uganda. BMC Family Practice 2013, 14:193 http://www.biomedcentral.com/1471-2296/14/193
17 Mazigo HD, Nuwaha F, Kinug’hi SM, Morona D, Pinot de Moira A, Wilson S, Heukelbach J, Dunne DW: Epidemiology and control of human schistosomiasis in Tanzania: Review Parasites & Vectors 2012, 5:274
18 Joaniter I. Nankabirwa, Bonnie Wandera, Pauline Amuge, , Noah Kiwanuka,  Grant Dorsey, Philip J. Rosenthal, Simon J. Brooker, Sarah G Staedke, Moses R. Kamya. Impact of intermittent preventive treatment with dihydroartemisinin-piperaquine on malaria in. Ugandan schoolchildren: a randomized placebo-controlled trial. Clin Infect Dis. May 15, 2014; 58(10): 1404–1412.
19  Kwizera R,  Nguna J,  Kiragga A,  Nakavuma J,  Rajasingham R, Boulware DR and Meya DB. Performance of Cryptococcal Antigen Lateral Flow Assay Using Saliva in Ugandans with CD4 <100. PLoS One. 2014; 9(7): e103156.
20 Matovu JK, Wanyenze RK, Wabwire-Mangen F, Nakubulwa R, Sekamwa R, Masika A, Todd J, Serwadda D. Men are always scared to test with their partners … it is like taking them to the Police”: Motivations for and barriers to couples’ HIV counselling and testing in Rakai, Uganda: a qualitative study. J Int AIDS Soc 2014, 17:19160
21 Ononge S, Campbell O, Mirembe F. Haemoglobin status and predictors of anaemia among pregnant women in Mpigi, Uganda.  BMC Res Notes [2014, 7:712
22 Mazigo HD, Dunne DW, Wilson S, Kinung’hi SM, Lwambo JS*, Jones FM, Pinot de Moira A, Todd J, Nuwaha F.Epidemiology and interactions of Human Immunodeficiency Virus – 1 and Schistosoma mansoni in sub-Saharan Africa. Infectious Diseases of Poverty 2013, 2:2
23 Galukande M,  Wabinga H, Mirembe F, Karamagi C, Asea A. Difference in Risk Factors for Breast Cancer by ER Status in an Indigenous African Population. ISRN Oncology Volume 2013, Article ID 463594 http://dx.doi.org/10.1155/2013/463594
24 D. Meya Elizabeth Nalintya, Mark Tenforde, Radha Rajasingham and Joe Jarvis.  Preventing Cryptococcosis – Shifting the paradigm in the era of Highly Active Antiretroviral Therapy” (DOI: 10.1007/s40475-015-0045-z) Accepted for publication in Tropical Medicine Reports
25 R. Kiguba, C Karamagi, P Waako, HB Ndagije and SM Bird. Rare, serious, and comprehensively described suspected adverse drug reactions reported by surveyed” PONE-D-14-44804 Accepted for publication in PLOS One.
26 D Mutabazi-Mwesigire, Achilles Katamba, Faith Martin, Janet Seeley, Albert W. Wu. Factors that affect Quality of life among people living with HIV attending an urban clinic in Uganda” PONE-D-14-35452. Accepted for publication in PLOS One.
27 HD Mazigo, D Dunne, D Morona, TE Lutufyo, SM Kinung’hi, G Kaatano, MD,MPH; Fred Nuwaha, MBcHB,MPH,PhD Periportal fibrosis, liver and spleen sizes among S. mansoni mono orco-infected individuals with Human Immunodeficiency Virus-1 in fishing villages along Lake Victoria shores, North-Western, Tanzania. Accepted for publication in Parasites & Vectors

Postdoc Fellowships Round One

1 Kavishe RA, Paulo P, Kaaya RD, Akili Kalinga, Zwetselaar MV, Chilongola J, Roper C and Alifrangis M. Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania. Malaria Journal 2014, 13:264 http://www.malariajournal.com/content/13/1/264
2 Mohammed A, Ndaro A, Kalinga A, Manjurano A, Mosha JF, Mosha DF, Zwetselaar MV, Koenderink JB, Mosha FW, Alifrangis M, Reyburn H, Roper C, Kavishe RA. Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania. Malaria Journal 2013, 12:415. http://www.malariajournal.com/content/12/1/415
3 Matondo SI, Temba GS, Kavishe AA, Kauki JS, Kalinga A, Zwetselaar MV, Reyburn H, and Kavishe RA, High levels of sulphadoxine-pyrimethamine resistance Pfdhfr-Pfdhps quintuple mutations: a cross sectional survey of six regions in Tanzania. Malaria Journal 2014, 13:152 http://www.malariajournal.com/content/13/1/152
4 Amone-P Olak K, Otim BN, Opio G, Ovuga E, Ovuga E, Meiser-Stedman R. War experiences and  psychotic symptoms among former child soldiers in Northern Uganda: the mediating role of    post-war hardships – the WAYS Study. South African Journal of Psychology, Published Online first: [24 Oct 2014]. [Epub ahead of print]. DOI: 10.1177/0081246314556567
5 Amone-P Olak K, Lekhutlile T, Meiser-Stedman R, Ovuga E. Mediators of the relation between war experiences and suicidal ideation among former child soldiers in Northern Uganda: the WAYS study. BMC Psychiatry. 2014 Sep 24;14(1):271. [Epub ahead of print] DOI:10.1186/s12888-014-0271-2
6 Amone-P’Olak K, Ovuga E, Croudace TJ, Jones PB, Abbott R. (In Press).The influence of different types of War experiences on depression and anxiety in a Ugandan cohort of war-affected youth: the WAYS  study. Social Psychiatry and Psychiatric Epidemiology. Published Online First: [10 April 2014]; 0:1–10.  DOI:10.1007/s00127- 014-0873-5
7 Amone-P’Olak K, Jones PB, Meiser-Stedman R, Abbott RA, Ayella-Ataro PS, A J, Ovuga E. War  experiences, general functioning and barriers to care among former child soldiers in Northern Uganda: the WAYS study. J Public Health 2014;0:1–9. DOI:10.1093/pubmed/fdt126
8 SW Wachira, S Omar, J W Jacob,  M Wahome, HT Alborn, DR Spring, DK Masiga, and B Torto. Toxicity of six plant extracts and two pyridine alkaloids from Ricinus communis against the malaria vector Anopheles gambiae. l. Parasites & Vectors 2014, 7:312 http://www.parasitesandvectors.com/content/7/1/312
9 Kavishe RA, Paulo P, Kaaya RD, Kalinga A, van Zwetselaar M, Chilongola J, Roper C, Alifrangis M. Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania. Malar J [2014, 13:264]
10 Mohammed A, Ndaro A, Kalinga A, Manjurano A, Mosha JF, Mosha DF, van Zwetselaar M, Koenderink JB, Mosha FW, Alifrangis M, Reyburn H, Roper C, Kavishe RA. Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania. Malaria Journal 2013, 12:415
11 Amone-P’Olak, K Lekhutile, TM, Ovuga, E; Meiser-Stedman, R; Abbott, RA, Jones, PB. Sexual violence and general functioning among formerly abducted girls in Northern Uganda: The mediating roles of stigma and community relations – the WAYS Study. Accepted for publication Social Science & Medicine 2014
12 Amone-P’Olak, K Jan Stochl, Peter B Jones, Richard Meiser-Stedman, Tim J Croudace, Emilio Ovuga. Categories of War Events, Age at Abduction, Duration in Captivity and Depression in a Ugandan Cohort of War-affected Youth – The WAYS Study Social Psychiatry and Psychiatric Epidemiology 2014
13 M, K Peter B. Jones, Rosemary Abbott, Richard Meiser-Stedman, Emilio Ovuga, Tim J. Croudace Cohort Profile: Mental Health Problems following extreme trauma in a northern Ugandan cohort of War-Affected YouthS (The WAYS Study) SpringerPlus 2013

Masters’ Research Fellows

1 Nanteza M, Tusiime JB, Kalyango J and Kasangaki A. Association between oral candidiasis and low CD4+ count among HIV positive patients in Hoima Regional Referral Hospital BMC Oral Health 2014, 14:143  doi:10.1186/1472-6831-14-143 S.
2 Mugaba, R. Nakiboneka, M. Nanyonjo, D. Bugembe-Lule, I. Kaddu, B. Nanteza, R. Tweyongyere, P. Kaleebu, J. Serwanga. Group M consensus Gag and Nef peptides are as efficient at detecting clade A1 and D cross-subtype T-cell functions as subtype-specific consensus peptides. Vaccine 2014: 32 (3787–3795)
3 Agnes Nyabigambo, Joshua Kanaabi Muliira, lynn Atuyambe, Harriet M Babikako, Andrew Kambugu, Christopher Ndoleriire. Determinants of utilization of a no-cost HiV transition clinic: a cross-sectional study of young adults living with HIV/AIDS. Adolescent Health, Medicine and Therapeutics 2014:5 89–99
4 Elichilia R. Shao, Emmanuel G. Kifaro, Innocent B. Chilumba, Balthazar M. Nyombi, Sikhulile MoyoSimani Gaseitsiwe, Rosemary MusondaAsgeir JohannessenGibson Kibiki and Max Essex HIV-1 drug mutations in children from northern Tanzania. J. Antimicrob. Chemother. 2014 doi: 10.1093/jac/dku087
5 Inzaule S, Otieno J, Kalyango J, Nafisa L, Kabugo C, Josephine Nalusiba, Daniel Kwaro, Clement Zeh, Charles Karamagi. (2014) Incidence and Predictors of First Line Antiretroviral Regimen Modification in Western Kenya. PLoS ONE 9(4): e93106. doi:10.1371/journal.pone.0093106
6 Prossy Namuwulya, Emily Abernathy, Henry Bukenya, Josephine Bwogi, Phionah Tushabe, Molly Birungi, Ronald Seguya, Theopista Kabaliisa, Vincent P. Alibu, Jonathan K. Kayondo, Pierre Rivailler, Joseph Icenogle and Barnabas Bakamutumaho. Phylogenetic Analysis of Rubella Viruses Identified in Uganda, 2003–2012. Journal of Medical Virology. DOI 10.1002/jmv.23935
7 Elizabeth J. Lyimo, Jim Todd, Lisa Ann Richey & Bernard Njau (2013) The association between social networks and self-rated risk of HIV infection among secondary school students in Moshi Municipality, Tanzania, SAHARA-J: Journal of Social Aspects of HIV/AIDS: An Open Access Journal, 10:3-4, 131-139, DOI:  10.1080/17290376.2014.888676
8 Ronald Kintu-Luwaga, Moses Galukande and Francis N Owori. Serum lactate and phosphate as biomarkers of intestinal ischemia in a Ugandan tertiary hospital: a cross-sectional study. International Journal of Emergency Medicine 2013, 6:44
9 Marwa B, Njau B, Kessy J, Mushi D. Feasibility of introducing compulsory community health fund in low resource countries: views from the communities in Liwale district of Tanzania. BMC Health Services Research 2013, 13:298 doi:10.1186/1472-6963-13-298
10 Haule C, Ongom PA, Kimuli. Efficacy of Gastrografin. Compared with Standard Conservative Treatment in Management of Adhesive. Small Bowel Obstruction at Mulago National Referral Hospital. J Clin Trials 2013: 3: 144. doi:10.4172/2167-0870.1000144.
11 Harriet Kagoya, Dan Kibule, Honore Mitonga-Kabwembe, Elizabeth Ekirapa-Kiracho, John Ssempebwa. Patients’ rights at Uganda’s National Referral Hospital: Awareness, Responsiveness and Practice. African Journal of Primary Health Care & Family Medicine 2013 5:1 doi: 10.4102/phcfm.v5i1.491

Pump-Priming Grantees

1 Musoke D, Miiro G, Karani G, Morris K, Kasasa S, Ndejjo R, Nakiyingi-Miiro J, Guwatudde D, Musoke MB. Promising Perceptions, Divergent Practices and Barriers to Integrated Malaria Prevention in Wakiso District, Uganda: A Mixed Methods Study. PLoS ONE 2015 10(4): e0122699. doi:10.1371/journal.pone.0122699
2 Serwanga J, Ritah Nakiboneka, Susan Mugaba, Brian Magambo, Nicaise Ndembi, Frances Gotch, Pontiano Kaleebu. Differences in patterns of Gag-induced immunogenetic pressure occur between clades A and D chronic HIV-1 infection in a Ugandan population. Retrovirology 2009;6(Suppl. 3):P380
3 Ponsiano Ocama. Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda” Accepted for publication in African Health Sciences.
4 Okello ES, Abbo C, Muhwezi WW, Akello B, Ovuga E. Mental health literacy among secondary school students in North and Central Uganda: a qualitative study. World Cultural Psychiatry Research Review 2014, 9 (3): 70-80
5 Kipanga PN, Omondi D, Mireji PO, Sawa P, Masiga DK and Villinger J. High-resolution melting analysis reveals low Plasmodium parasitaemia infections among microscopically negative febrile patients in western Kenya. Kipanga et al. Malaria Journal 2014, 13:429 http://www.malariajournal.com/content/13/1/429
6 Bayo P, Ochola E, Oleo C, Mwaka AD. High prevalence of hepatitis B virus infection among pregnant women attending antenatal care: a cross-sectional study in two hospitals in northern Uganda. BMJ Open 2014;4: e005889. doi:10.1136/ bmjopen-2014-005889
7 Rachel Manongi, Frank Mtei, George Mtove, Behzad Nadjm, Florida Muro, Victor Alegana, Abdisalan M. Noor, Jim Todd and Hugh Reyburn. Inpatient child mortality by travel time to hospital in a rural area of Tanzania 2014. Tropical Medicine and International Health 2014 (5): 555–562 doi:10.1111/tmi.1229419
8 Kiwanuka N, Ssetaala A, Nalutaaya A, Mpendo J, Wambuzi M, et al. (2014) High Incidence of HIV-1 Infection in a General Population of Fishing Communities around Lake Victoria, Uganda. PLoS ONE 9(5): e94932. doi:10.1371/journal.pone.0094932
9 Ian Guyton Munabi, William Buwembo, David Lagoro Kitara, Joseph Ochieng, Rose Chalo Nabirye, Erisa Sabakaki Mwaka. Musculoskeletal disorders among nursing staff: a comparison of five hospitals in Uganda. The Pan African Medical Journal. 2014;17:81
10 Ian G Munabi, William Buwembo, David L Kitara, Joseph Ochieng and Erisa S Mwaka. Musculoskeletal disorder risk factors among nursing professionals in low resource settings: a cross-sectional study in Uganda. BMC Nursing 2014, 13:7  doi:10.1186/1472-6955-13-7
11 Joel M. Francis, Heiner Grosskurth, John Changalucha, Saidi Kapiga, Helen A. Weiss.  : systematic review and meta-analysis. Tropical Medicine and International Health Journal. 31 JAN 2014 | DOI: 10.1111/tmi.12267
11 Charles Odongo, Denis Anywar, Kenneth Luryamamoi, Pancras Odongo Antibiograms from community-acquired uropathogens in Gulu, northern Uganda – a cross-sectional study. BMC Infectious Diseases 2013, 13:193
12 Noah Kiwanuka, Ali Ssetaala, Juliet Mpendo, Matthias Wambuzi, Annet Nanvubya, Simon Sigirenda. Annet Nalutaaya, Paul Kato, Leslie Nielsen, Pontiano Kaleebu, Josephine Nalusiba and Nelson K Sewankambo.  High HIV-1 prevalence, risk behaviours, and willingness to participate in HIV vaccine trials in fishing communities on Lake Victoria, Uganda. Journal of the International AIDS Society 2013, 16:18621
13 Kiwanuka N, Mpendo J, Nalutaaya A, Wambuzi M, Nanvubya A, Kitandwe PK, Muyanja E, Ssempiira J, Balyegisawa A, Ssetaala A, UVRI-IAVI Research Team. An assessment of fishing communities around Lake Victoria, Uganda, as potential populations for future HIV vaccine efficacy studies: an observational cohort study. BMC Public Health [2014, 14:986]
14 LM Atuyambe, SPS Kibira, J Bukenya, C Muhumuza, R Apolot, E Mulogo. Understanding sexual and reproductive health needs of  adolescents: evidence from a formative evaluation in Wakiso district, Uganda. Accepted for publication in Reproductive Health MS ID: 1892833721130857

Joint Publications

1 Okal MN, Francis B, Herrera-Varela M, Fillinger U, Lindsay SW (2013) Water vapour is a pre-oviposition attractant for the malaria vector Anopheles gambiae sensu stricto.  Malar J, 12:365
2 Dugassa, S; Lindh, JM; Oyieke, F; Mukabana, WR; Lindsay, SW; Fillinger, U; (2013) Development of a Gravid Trap for Collecting Live Malaria Vectors Anopheles gambiae s.l. PloS one, 8 (7). ISSN 1932-6203 DOI: 10.1371/journal.pone.0068948
3 Mbare, O; Lindsay, SW; Fillinger, U; (2013) Dose-response tests and semi-field evaluation of lethal and sub-lethal effects of slow release pyriproxyfen granules (Sumilarv (R) 0.5G) for the control of the malaria vectors Anopheles gambiae sensu lato. Malaria journal, 12. ISSN 1475-2875 DOI: 10.1186/1475-2875-12-94
4 Tusting, LS; Thwing, J; Sinclair, D; Fillinger, U; Gimnig, J; Bonner, KE; Bottomley, C; Lindsay, SW; (2013) Mosquito larval source management for controlling malaria. Cochrane database of systematic reviews (Online), 8. CD008923. ISSN 1469-493X DOI: 10.1002/14651858.CD008923.pub2
5 Dugassa S, Lindh JM, Torr SJ, Oyieke F, Lindsay SW, Fillinger U: Electric nets and sticky materials for analysing oviposition behaviour of gravid malaria vectors. Malar J, 2012, 11:374
6 Chaki, PP; Dongus, S; Fillinger, U; Kelly, A; Killeen, GF; (2011) Community-owned resource persons for malaria vector control: enabling factors and challenges in an operational programme in Dar es Salaam, United Republic of Tanzania. Human resources for health, 9. ISSN 1478-4491 DOI: 10.1186/1478-4491-9-21
7 Ndenga, BA; Simbauni, JA; Mbugi, JP; Githeko, AK; Fillinger, U; (2011) Productivity of Malaria Vectors from Different Habitat Types in the Western Kenya Highlands. PloS one, 6 (4). e19473. ISSN 1932-6203 DOI: 10.1371/journal.pone.0019473
8 Thwing, J; Fillinger, U; Gimnig, J; Newman, R; Lindsay, S; (2011) Mosquito larval source management for controlling malaria. Cochrane Database of Systematic Reviews (1). DOI: 10.1002/14651858.CD008923
9 Castro, MC; Kanamori, S; Kannady, K; Mkude, S; Killeen, GF; Fillinger, U; (2010) The importance of drains for the larval development of lymphatic filariasis and malaria vectors in Dar es Salaam, United Republic of Tanzania. PLoS neglected tropical diseases, 4 (5). e693. ISSN 1935-2727 DOI: 10.1371/journal.pntd.0000693
10 Imbahale, SS; Fillinger, U; Githeko, A; Mukabana, WR; Takken, W; (2010) An exploratory survey of malaria prevalence and people’s knowledge, attitudes and practices of mosquito larval source management for malaria control in western Kenya. Acta tropica, 115 (3). pp. 248-256. ISSN 0001-706X DOI: 10.1016/j.actatropica.2010.04.005
11 Chaki, PP; Govella, NJ; Shoo, B; Hemed, A; Tanner, M; Fillinger, U; Killeen, GF; (2009) Achieving high coverage of larval-stage mosquito surveillance: challenges for a community-based mosquito control programme in urban Dar es Salaam, Tanzania. Malaria journal, 8. ISSN 1475-2875
12 Fillinger, U; Ndenga, B; Githeko, A; Lindsay, SW; (2009) Integrated malaria vector control with microbial larvicides and insecticide-treated nets in western Kenya: a controlled trial. Bulletin of the World Health Organization, 87 (9). pp. 655-65. ISSN 0042-9686 DOI: 10.2471/BLT.08.055632
13 Geissbuhler, Y; Kannady, K; Chaki, PP; Emidi, B; Govella, NJ; Mayagaya, V; Kiama, M; Mtasiwa, D; Mshinda, H; Lindsay, SW; Tanner, M; Fillinger, U; de Castro, MC; Killeen, GF; (2009) Microbial larvicide application by a large-scale, community-based program reduces malaria infection prevalence in urban Dar es Salaam, Tanzania. PloS one, 4 (3). e5107. ISSN 1932-6203 DOI: 10.1371/journal.pone.0005107
14 Nakimuli, A; Chazara, O; Byamugisha, J; Elliott, AM; Kaleebu, P; Mirembe, F; Moffett, A; (2014) Pregnancy, parturition and preeclampsia in women of African ancestry. American journal of obstetrics and gynecology, 210 (6). 510-U270. ISSN 0002-9378 DOI: 10.1016/j.ajog.2013.10.879
15 Tann, CJ; Nkurunziza, P; Nakakeeto, M; Oweka, J; Kurinczuk, JJ; Were, J; Nyombi, N; Hughes, P; Willey, BA; Elliott, AM; Robertson, NJ; Klein, N; Harris, KA (2014) Prevalence of Bloodstream Pathogens Is Higher in Neonatal Encephalopathy Cases vs. Controls Using a Novel Panel of Real-Time PCR Assays. PLoS One, 9 (5). e97259. ISSN 1932-6203 DOI: 10.1371/journal.pone.0097259
16 Vandepitte, J; Hughes, P; Matovu, G; Bukenya, J; Grosskurth, H; Lewis, DA; (2014) High prevalence of ciprofloxacin-resistant gonorrhea among female sex workers in kampala, Uganda (2008-2009). Sexually transmitted diseases, 41 (4). pp. 233-7. ISSN 0148-5717 DOI: 10.1097/OLQ.0000000000000099
17 Wammes, LJ; Mpairwe, H; Elliott, AM; Yazdanbakhsh, M; (2014) Helminth therapy or elimination: epidemiological, immunological, and clinical considerations. The Lancet infectious diseases. ISSN 1473-3099 DOI: 10.1016/S1473-3099(14)70771-6
18 Biraro S, Ruzagira E, Kamali A, Whitworth J, Grosskurth H, Weiss HA: HIV- transmission within Marriage in Rural Uganda: A Longitudinal Study. PLoS One. 2013;8(2):e55060
19 Kiwuwa-Muyingo, Sylvia; Oja, Hannu; Walker, AnnSarah; Ilmonen, Pauliina; Levin, Jonathan; Mambule, Ivan; Reid, Andrew; Mugyenyi, Peter; Todd, Jim; Dart Trial, Team; (2013) Dynamic logistic regression model and population attributable fraction to investigate the association between adherence, missed visits and mortality: a study of HIV-infected adults surviving the first year of ART. Bmc Infectious Diseases, 13. ISSN 1471-2334 DOI: 10.1186/1471-2334-13-395
21 Kizito D, Tweyongyere R, Namatovu A, Webb EL, Muhangi L, Lule SA, Bukenya H, Cose S, Elliott AM; Factors affecting the infant antibody response to measles immunisation in Entebbe-Uganda. BMC Public Health. 2013 Jul 1;13:619. doi: 10.1186/1471-2458-13-619 PMID: 23816281
21 Muhangi L, Lule SA, Mpairwe H, Ndibazza J, Kizza M, Nampijja M, Nakazibwe E, Kihembo M, Elliott AM, Webb E; Maternal HIV infection and other factors associated with growth outcomes of HIV-uninfected infants in Entebbe, Uganda. Public Health Nutr. 2013 Sep;16(9):1548-57. doi: 10.1017/S1368980013000499. Epub 2013 Mar 18 PMID: 23507372
22 Nakimuli A, Chazara O, Byamugisha J, Elliott AM, Kaleebu P, Mirembe F, Moffett A; Pregnancy, parturition and preeclampsia in women of African ancestry. Am J Obstet Gynecol. 2013 Oct 30. pii: S0002-9378(13)01989-3. doi: 10.1016/j.ajog.2013.10.879. [Epub ahead of print]; PMID: 24184340
23 Nakimuli A, Chazara O, Farrell L, Hiby SE, Tukwasibwe S, Knee O, Jayaraman J, Traherne JA, Elliott AM, Kaleebu P, Mirembe F, Moffett A; Killer cell immunoglobulin-like receptor (KIR) genes and their HLA-C ligands in a Ugandan population. Immunogenetics. 2013 Aug 24. [Epub ahead of print] PMID: 23974321
24 Ndibazza J, Webb EL, Lule S, Mpairwe H, Akello M, Oduru G, Kizza M, Akurut H, Muhangi L, Magnussen P, Vennervald B, Elliott A; Associations between maternal helminth and malaria infections in pregnancy and clinical malaria in the offspring: a birth cohort in entebbe, Uganda. J Infect Dis. 2013 Dec;208(12):2007-16. doi: 10.1093/infdis/jit397. Epub 2013 Jul 31. PMID: 23904293
25 Nsubuga, RN; Maher, D; Todd, JE; (2013) Impact of antiretroviral therapy on adult HIV prevalence in a low-income rural setting in Uganda: a longitudinal population-based study. Journal of acquired immune deficiency syndromes (1999), 62 (5). pp. 562-8. ISSN 1525-4135 DOI: 10.1097/QAI.0b013e3182847033
26 Todd, J; Heyderman, RS; Musoke, P; Peto, T; (2013) When enough is enough: how the decision was made to stop the FEAST trial: data and safety monitoring in an African trial of Fluid Expansion As Supportive Therapy (FEAST) for critically ill children. Trials, 14. p. 85. ISSN 1745-6215 DOI: 10.1186/1745-6215-14-85
27 Tweyongyere R, Naniima P, Mawa PA, Jones FM, Webb EL, Cose S, Dunne DW, Elliott AM; Effect of Maternal Schistosoma mansoni Infection and Praziquantel Treatment During Pregnancy on Schistosoma mansoni Infection and Immune Responsiveness among Offspring at Age Five Years. PLoS Negl Trop Dis. 2013 Oct 17;7(10):e2501. doi: 10.1371/journal.pntd.0002501. PMID: 24147175, PMCID: PMC3798616
28 Vandepitte J, Weiss HA, Kyakuwa N, Nakubulwa S, Muller E, Buvé A, Van der Stuyft P, Hayes R, Grosskurth H. Natural history of Mycoplasma genitalium Infection in a Cohort of Female Sex Workers in Kampala, Uganda. Sex Transm Dis. 2013 May;40(5):422-7
29 Wakeham K, Webb EL, Sebina I, Nalwoga A, Muhangi L, Miley W, Johnston WT, Ndibazza J, Whitby D, Newton R, Elliott AM; Risk factors for seropositivity to Kaposi’s sarcoma associated herpesvirus (KSHV) among children in Uganda. J Acquir Immune Defic Syndr. 2013 Jun 1;63(2):228-33. doi: 10.1097/QAI.0b013e31828a7056. PMID: 23403859
30 Anderson EJ, Webb EL, Mawa PA, Kizza M, Lyadda N, Nampijja M, Elliott AM; The influence of BCG vaccine strain on mycobacteria-specific and non-specific immune responses in a prospective cohort of infants in Uganda. Vaccine. 2012 Mar 9;30(12):2083-9. Epub 2012 Jan 31. PMID: 22300718; PMCID: PMC3314967
31 Fennelly KP, Jones-López EC, Ayakaka I, Kim S, Menyha H, Kirenga B, Muchwa C, Joloba M, Dryden-Peterson S, Reilly N, Okwera A, Elliott AM, Smith PG, Mugerwa RD, Eisenach KD, Ellner JJ;  Variability of Infectious Aerosols Produced During Coughing by Patients with Pulmonary Tuberculosis. Am J Respir Crit Care Med. 2012 Sep 1;186(5):450-7. Epub 2012 Jul 12. PMID: 22798319; PMCID: PMC3443801
32 Kasamba I, Baisley K, Mayanja B, Maher D, Grosskurth H: The impact of antiretroviral treatment on mortality trends of HIV-positive adults in rural Uganda: a longitudinal population-based study, 1999-2009.  TMIH June 2012;  e66-73
33 Kiwuwa-Muyingo, S; Walker, AS; Oja, H; Levin, J; Miiro, G; Katabira, E; Kityo, C; Hakim, J; Todd, J; the DART Trial Team; (2012) The impact of first year adherence to antiretroviral therapy on long-term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe. Tropical medicine & international health. ISSN 1360-2276 DOI: 10.1111/j.1365-3156.2012.02974.x
34 Lule SA, Webb EL, Ndibazza J, Nampijja M, Muhangi L, Akello F, Kakande M, Kizindo R, Elliott AM; Maternal recall of birthweight and birth size in Entebbe, Uganda. Trop Med Int Health. 2012 Sep 20. doi: 10.1111/j.1365-3156.2012.03091.x. [Epub ahead of print] PMID: 22994260; PMCID: PMC3627817
35 Medina Lara A, Kigozi J, Amurwon J, Muchabaiwa L, Nyanzi Wakaholi B, Mujica Mota RE, Walker AS, Kasirye R, Ssali F, Reid A, Grosskurth H, Babiker AG, Kityo C, Katabira E, Munderi P, Mugyenyi P, Hakim J, Darbyshire J, Gibb DM, Gilks CF; on behalf of the DART Trial Team. Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.  PLoS One. 2012;7(4):e33672
36 Munderi P, Grosskurth H, Droti B, Ross DA. What are the essential components of   HIV treatment and care services in low and middle-income countries? An overview by settings and levels of the health? AIDS 2012 Dec;26 Suppl 2:S97-S103
37 Munyagwa M, Baisley K, Levin J, Brian M, Grosskurth H, Maher D: Mortality of HIV-infected and uninfected children in a longitudinal cohort in rural south-west Uganda during 8 years of follow-up. Trop Med Int Health. 2012; 17: 836-43
38 Nampijja M, Apule B, Lule S, Akurut H, Muhangi L, Webb EL, Lewis C, Elliott AM, Alcock KJ; Effects of Maternal Worm Infections and Anthelminthic Treatment during Pregnancy on Infant Motor and Neurocognitive Functioning. J Int Neuropsychol Soc. 2012 Nov;18(6):1019-30. doi: 10.1017/S1355617712000768. PMID: 23158229
39 Ndibazza J, Mpairwe H, Webb EL, Mawa PA, Nampijja M, Muhangi L, Kihembo M, Lule SA, Rutebarika D, Apule B, Akello F, Akurut H, Oduru G, Naniima P, Kizito D, Kizza M, Kizindo R, Tweyongere R, Alcock KJ, Muwanga M, Elliott AM; Impact of anthelminthic treatment in pregnancy and childhood on immunisations, infections and eczema in childhood: a randomised controlled trial. PLoSOne. 2012;7(12):e50325. doi: 10.1371/journal.pone.0050325. Epub 2012 Dec 7. PMID: 23236367; PMCID: PMC3517620
40 Nkurunungi G, Lutangira JE, Lule SA, Akurut H, Kizindo R, Fitchett JR, Kizito D, Sebina I, Muhangi L, Webb EL, Cose S, Elliott AM; Determining Mycobacterium tuberculosis Infection among BCG-Immunised Ugandan Children by T-SPOT.TB and Tuberculin Skin Testing. PLoS One. 2012;7(10):e47340. doi: 10.1371/journal.pone.0047340. Epub 2012 Oct 15. PMID: 23077594; PMCID: PMC3471887

CPE Outputs

1 Furaha Comic Book

Furaha has become healthy and an ambassador for advocating for a healthy lifestyle. This comic book has been prepared by students of St. Mary Goretti Secondary School in Kilimajaro, Tanzania. Its contents draw on the research of Mary Vincent Mosha, a THRiVE-2 PhD fellow. The comic book will be used by primary school children as a guide for healthy living.

comic book_english

Policies

Policy on postdoctoral position

Makerere University needs to develop and consolidate PDF positions in the University academic hierachy as an essential and important support to its ever growing research enterprise. PDFs will play a key role and significant contribution in achieving Makerere’s goal of becoming a research driven University. Moreover as doctoral training is taking a strong hold at the University there is urgent need to complete the value chain in growing independent researchers as is the case elsewhere globally

THRiVE Finance SOPs

Standard Operating Procedures for THRiVE-2 DELTAS AFRICA

These SOPs serve to guide Finance Officers handling transactions on THRiVE-2 DELTAS Africa.

  1. All resources for THRiVE-2 DELTAS Africa must be used for the purpose for which the grant/project was set out to do and if the Institution is to deviate in any way a request for a no objection must be obtained from the Director THRiVE-2.
  2. The Director/ co applicant in an institution must approve all transactions.
  3. Each request should indicate the budget line from which funds are to be Charged/ drawn.
  4. All procurements should follow the institutional/ National guidelines.
  5. Payments for workshops, conferences etc. should have supporting documents i.e. Justification, Minutes authorizing the activity, list of participants, etc.
  6. All payments should have statutory deductions according to the National Tax policy of the relevant country e.g. withholding tax, PAYE, NSSF.
  7. All funds Transferred from Lead to partners institutions and from Funder to Lead institution must be acknowledged for by the partners and the Lead respectively.
  8. The date posted in the cashbook is the initial payment transaction date or system loading date or cheque date depending on the system in use.
  9. All people paid on the project must have appointment letters.
  10. When funds have been released for an activity, no individual should request for an advance for the same activity before the previous advance is accounted for.
  11. Requests for advance for an activity should not exceed a period of three months to absorb the funds.
  12. All advances for fieldwork, purchases, etc. must be accounted for in full and within the period prescribed by the law of the Country. For example for Makerere University, within 14 days or not exceeding 60 days after the activity has ended
  13. No advance amount that crosses a financial year should be authorized. All advances should cease by the end of the financial year, March 31 2017.
  14. If the activity crosses a financial year for example goes beyond 31st March, the balance of money on the activity must be banked and drawn again after the end of the financial year e.g. 1st April of the next financial year.
  15. All accountabilities for advances for field works or any other activity should have proceedings/reports, list of people who attended with their signatures appended.
  16. For travel abroad all expenditures are according to the AESA guidelines.
  17. There must be Stores records in place for all supplies. A record of what comes in and what goes out must always be kept.
  18. There must be an Assets Register detailing the following:- Date of Purchase, Description of Asset, Cost, Location, Supplier, Condition, Serial No., Marked no or Engraved No. and Remarks. All assets must be marked/ engraved and the name of the project must be included.
  19. All vehicles if any should have mileage log books indicating, distance moved, cost of fuel, services. There should be a ledger for repair costs. Fuel must be processed according to the institutional policy.
  20. All documents must be filed chronologically. For example all vouchers must be filed according to cheque numbers and or voucher numbers or serially system generated numbers. All vouchers/documents for paid transactions must be identified as ‘paid’.
  21. Bank Reconciliations must be done monthly and must indicate who prepared and who reviewed it.
  22. Borrowing THRiVE-2 funds is prohibited. If you must, seek for a no objection from the Director.
  23. After the project closure, disposal or sharing assets must follow the Institutional policy. However, a report must be submitted to the Director before implementation.
  24. Each institution is to Provide Audited Accounts to The Director who will pass them on to the Funder each year.
  25. Comingling of funds is not allowed. Separate Bank Accounts for GBP and Local currency should be opened in a bank of rating A or higher. Any deviation requires a no objection from The Director.
  26. Any Interest accrued must be used for the purpose of the Grant.
  27. Co- Applicants should submit quarterly reports to the lead by the 15th day of the proceeding month after the Quarter end. Documents may be attached to the financial reports as may be required.
  28. The Lead Institution shall submit Quarterly Financial Reports to AESA by the end of the proceeding month
  29. The lead institution will hold funds and monitor how much to send to Partners according to their spending pattern/ absorption capacity.

Teefe Paul
THRiVE 2 DELTAS FINANCE OFFICER

Data and Information Security Policy

Minimum benchmark standard for computer and information Security

All computing devices fully or partially procured by THRiVE funds or any computers used to perform THRiVE activities must comply to the following minimum security requirements to ensure safety of the equipment and data.

THRiVE Information Technology Policy

THRiVE_IT_Policy

In an effort to ensure security of all technology and information procured and/or supported  by  THRiVE  funds,  THRiVE  secretariat  at  Makerere  University  has  put together an Information and Technology Policy to guide the use of technology and acquisition, access, process, and storage of information. The policy was developed in consultation with Makerere University Directorate of Information and Communication Technology (DICTS), with technical support by the Wellcome Trust IT Service Delivery & Operations manager.

The policy lays out the responsibilities of persons who use technology or handle information that are acquired partially or fully using THRiVE funds. Each person has a responsibility for making informed  decisions and  ensuring that THRiVE Technology and any information acquired or accessed, is handled securely and responsibly,  especially  when  data  and  information  is  of  a  sensitive  or  confidential nature.

THRiVE Partner Managment Policy

The manual was prepared to guide the technical and financial management of the consortium and to ensure effective value for money in all partner activities that will be involved in the direct implementation of the program. The manual is designed to ensure that the program is administered with proper financial stewardship and that funds are put to the intended use and according to the requirements of the program to meet set targets as per the award.

THRiVE Partner Managment Policy

THRiVE Anti-Fraud and Anti-Corruption Policy

Fraudulent, corrupt and/or collusive practices are contrary to THRiVE’s core values. THRiVE recognizes the adverse effect that such practices could have on its activities and operations, and is committed to preventing them and taking robust action where they are found to occur.

THRiVE Anti-Fraud and Anti-Corruption Policy

THRiVE Whistleblower Guidelines

THRiVE is committed to operating within the highest standards of openness,
integrity and accountability and in compliance with all applicable laws, rules and regulations for staff, and prohibits fraudulent practices by any of its governance committee members, employees, fellows, students or volunteers, who are required to observe high standards of professional ethics and practice honesty and integrity in the conduct of their duties and responsibilities.

THRiVE Whistleblower Guidelines 

THRiVE Risk-management Plan

Risk management is an ongoing process that continues through the life of a project. It includes processes for risk management planning, identification, analysis, monitoring and control. Many of these processes are updated throughout the project lifecycle as new risks can be identified at any time. On the other hand, any event that could have a positive impact should be exploited. THRiVE Risk-management Plan

Subscribe
to our newsletter

"call for phd fellowships: Reducing the impact of Rheumatic Heart disease across the life span"

Training and Mentorship

ADM 2
PhD Training

The THRiVE consortium has provided financial support to fourteen East African students for four year PhD fellowships.

PHD
Post Doctoral Training

THRiVE has supported up to ten (10) Postdoctoral fellowship training in the region.

1
Msc Research Fellowships

THRiVE has offered 32 masters research fellowships to the best students pursuing master’s degree programmes.

26
September
  • 9:00 am to 4:00 pm
  • Makerere University College of Health Science Conference Room
THRiVE PhD Defense: Martin Mbonye

THRiVE in the Media

See all multimedia

THRiVE by the number

79
Fellows
Supported No. of Fellows since 2010
400
Publications
Publications spawned between THRiVE partners since 2010
300
Supervisors
First class potential supervisors with expertise in research